A synthesised short peptide from the Khavinson bioregulator programme, directed at bronchial and lung tissue and studied for respiratory tissue maintenance.

Why would lung tissue need a maintenance peptide?

Because the lungs cannot be a sealed barrier the way skin is. They process around eleven thousand litres of air a day along with whatever it carries, which places continuous demand on repair processes in that lining.

How strong is the evidence?

Limited. The published work is preclinical and comes largely from the originating institute, with little independent replication. There is no regulatory approval anywhere.

Why is bronchial tissue unusual?

Because it is continuously exposed to unfiltered outside air along with everything suspended in it. Unlike most internal tissue, it faces a constant load rather than occasional damage, which is why maintenance rather than repair is the research framing.

What is the mucociliary escalator?

The bronchial lining secretes a sticky mucus layer that traps incoming particles, and millions of tiny hairs called cilia beat in coordinated waves beneath it, pushing that layer steadily upward and out at roughly a centimetre a minute. It runs continuously without conscious involvement.

Research Library›Bioregulators & Neuropeptides›Bronchogen

Respiratory Bioregulator

Bronchogen: The Peptide for the Tissue That Meets the Outside World

A short peptide aimed at bronchial tissue — the lining of an organ that processes thousands of litres of unfiltered air every day.

5 min read·4 studies cited·Updated July 2026

Evidence level

Preclinical only — animal and cell studies

What this level means

Quick Reference

Sequence	Ala-Glu-Asp-Leu (AEDL)
Target tissue	Lungs / bronchi
Generation	Synthetic (second-generation)
Family	Khavinson bioregulators

What Is Bronchogen?

Bronchogen is a synthesised short peptide from the Khavinson family, directed at bronchial and lung tissue. The name follows the family convention — Broncho-gen, from bronchi.

What the lungs actually deal with, in plain language: your skin is a sealed barrier, but your lungs cannot be. To do their job they must let the outside world in — around eleven thousand litres of air a day, carrying whatever happens to be in it: dust, smoke, pollen, bacteria, viruses. It is as though one room in a house had to keep its windows permanently open while every other room stayed sealed. That room needs a far more active cleaning and repair operation than the rest, and it wears accordingly. Research on respiratory bioregulators starts from that observation.

What the Research Examines

Published work examines Bronchogen in the context of respiratory tissue maintenance, looking at markers of bronchial epithelial function and at responses to inflammatory and oxidative stress in lung tissue models.

As with most of the synthesised family, the evidence is preclinical and originates chiefly from the developing institute. Independent replication is limited and there is no regulatory approval in any jurisdiction.

The Cleaning System You Never Notice

The bronchial lining faces a problem no internal organ shares: it is continuously exposed to unfiltered outside air, and everything suspended in that air arrives with it — dust, smoke, pollen, bacteria, fungal spores.

The solution is a moving walkway made of mucus. The lining secretes a thin sticky layer that traps incoming particles, and beneath it sit millions of tiny hairs called cilia, beating in coordinated waves. The waves push the mucus layer steadily upward and out — roughly a centimetre a minute, continuously, without any conscious involvement.

It is a conveyor belt running in the background of every breath you have ever taken. Think of an escalator you cannot switch off, carrying the day's dirt out of the building. When it works you never think about it; when it stops working, everything it was carrying stays put.

This is why bronchial tissue is a research target for maintenance rather than repair. The barrier is not damaged occasionally — it is under load every minute of every day, and the machinery clearing it has to keep pace.

Frequently Asked Questions

Compiled by the Southern Pacific Labs research team. Last updated July 2026.

Browse the research range →

Published References

Khavinson VK, Malinin VV. “Gerontological Aspects of Genome Peptide Regulation.” Karger AG, Basel, 2005. Source
Anisimov VN, Khavinson VKh. “Peptide bioregulation of aging: results and prospects.” Biogerontology, 2010. PubMed
Khavinson VKh. “Peptides and Ageing.” Neuro endocrinology letters, 2002. PubMed
Fedoreyeva LI, Kireev II, Khavinson VKh, et al. “Penetration of short fluorescence-labeled peptides into the nucleus in HeLa cells and in vitro specific interaction of the peptides with deoxyribooligonucleotides and DNA.” Biochemistry. Biokhimiia, 2011. PubMed